Genedata Wins Swiss Biotech Success Story Award

Basel-headquartered developer of advanced software solutions recognized for success in digitalization of the global biotech industry

Esteemed Healthcare Executive, Michael Neeb, Named physIQ Special Advisor

Research from Beacon Biosignals Presented at Alzheimer's Association International Conference

The researchers concluded that automated analysis of EEG data is a promising way to stratify patients and track disease progression, while enabling better patient selection for clinical trials.

AVIA Releases Novel Benchmarking Data Revealing Health Systems’ Progress on Digital Consumerism Strategies

ChargePoint Technology bolsters growth strategy with key appointment

Sapio Sciences announces release with AI Based enhancements to accelerate discovery

Sapio Sciences releases a new version of their ELN and LIMS software complete with AI advancements.

BioIVT Acquires Cypex, a Leading Manufacturer of Drug-metabolizing Enzymes

Cypex’s recombinant xenobiotic metabolizing enzymes complement BioIVT’s extensive portfolio of hepatocytes and related hepatic products for drug research and development.

European pharma needs to keep manufacturing on the continent and become more digitised to stay competitive, say speakers at new event

The newly announced agenda for Connect in Pharma focuses on innovation as the foundation of a strong pharmaceutical industry in Europe. In order to ensure a strong future for European pharma, businesses need to prioritise digitalisation and maintain control of production lines, say two speakers due to present at the Geneva-based event in September.

Service Portfolio Expanded for Drug Delivery Research

Antibiotic Research UK Announces New CEO

The charity Antibiotic Research UK welcomes Jonathan Pearce as the new CEO, effective 1 August 2022. He takes over the position from founder Professor Colin Garner, who retired at the end of July 2022.

Trace Metal Analysis: An Established Technique Driving Advances in Alternative Energy Materials

Peptides for Diabetes Research—a Special Offer of BOC Sciences

BOC Sciences has been constantly enriching its peptide product library for years. Its peptides for diabetes research are recently brought into focus due to the growing concerns on this problem.

Stable and Quality Supply of Phosphoramidites Is a Reality at BOC Sciences

As an expert in chemistry, BOC Sciences understands how important the quality of phosphoramidite is to successful oligo synthesis and remarkably, it has taken concrete actions to manufacture certified products.

BOC Sciences Shares Its Strategic Emphasis on NTPs during the Pandemic

"Whether your studies involve DNA sequencing, cDNA synthesis, RT-PCR, RCA, MDA, DNA labeling, in vitro transcription, siRNA synthesis, or RNA amplification, we stock hundreds of modified or natural NTPs to suit your various molecular biological applications," a BOC Sciences manager announces to the public.

Vaxess Announces Launch of Phase 1 Trial For H1 Influenza Vaccine Patch

Company focused on creating shot-free future of vaccines; first human trial of Vaxess MIMIX™ vaccine patch will focus on administering influenza vaccine

Lyniate Merges with CareCom, Further Extending Capabilities of Interoperability Leader

Creative Biogene Launches Zebrafish Disease Models to Support Drug Discovery and Toxicology Research

IntegrateRNA Launches GalNAc-Oligonucleotide Conjugation Service to Support Oligonucleotides Therapeutic Research

MicroRNA Agomir Synthesis: Supporting New Drug Research with Cutting-Edge Chemical Synthesis Technology

Creative Bioarray Offers Clonality Analysis Service to Accelerate Biopharmaceutical or Biosimilar Development